IDEX Corporation ($IEX) Stock Forecast: Up 5.8% Today

What is IDEX Corporation?

IDEX Corporation (IEX) is a company that specializes in creating reliable solutions, enhancing quality of life, and achieving progress. Its operations encompass a variety of sectors, such as Health & Science Technologies, Fire & Safety/Diversified Products, and Fluid & Metering Technologies.

Why is IDEX Corporation going up?

IEX stock is up 5.8% on Apr 29, 2026 19:41

• IDEX Corporation (IEX) posted impressive Q1 2026 financial results, surpassing both EPS and revenue expectations, leading to a notable increase in its stock value.
• The exceptional performance was mainly due to strong growth in its Health & Science Technologies segment and strategic investments in key markets.
• Company leaders emphasized consistent innovation, strategic capital utilization, and a solid order backlog in HST as pivotal elements bolstering a positive outlook amidst global uncertainties.
• The decision to raise its projected full-year EPS guidance for 2026 additionally boosted investor confidence in IDEX's sustained growth path.

IEX Price Chart

IEX Technical Analysis

IEX News

Earnings call transcript: IDEX beats Q1 2026 forecasts, stock jumps

IDEX Corporation reported strong Q1 2026 results, surpassing EPS and revenue forecasts, which led to a 7.21% stock surge in pre-market trading. The company raised its full-year EPS guidance for 2026, driven by robust performance in its Health & Science Technologies segment and strategic focus on advantage markets. Executives highlighted consistent innovation, effective capital deployment, and the strong backlog in HST as key factors for continued optimism despite some geopolitical uncertainties.

https://www.investing.com/news/transcripts/earnings-call-transcript-idex-beats-q1-2026-forecasts-stock-jumps-93CH-4645790

Earnings call transcript: IDEX beats Q1 2026 forecasts, stock jumps

IDEX Corporation reported strong Q1 2026 financial results, exceeding analyst expectations with an EPS of $2.00 and revenue of $887 million. The company's stock jumped over 7% in pre-market trading, and it raised its full-year EPS guidance for 2026, driven by robust performance in its Health & Science Technologies segment and strategic investments. Executives discussed the sustained growth in advantage markets, the impact of 80/20 strategies, and cautious optimism for short-cycle industrial businesses amidst geopolitical uncertainties.

https://m.investing.com/news/transcripts/earnings-call-transcript-idex-beats-q1-2026-forecasts-stock-jumps-93CH-4645790?ampMode=1

Bunge Global Releases Q1 2026 Financial Results

Bunge Global SA reported a strong Q1 2026, surpassing Wall Street expectations with adjusted earnings of $1.83 per share against an estimated $0.90, and revenue surging to $21.86 billion. The growth was primarily driven by high commodity prices and robust global demand, particularly in its Soybean Processing and Refining segment. The company also provided optimistic full-year EPS guidance between $9.00 and $9.50, reflecting continued positive momentum.

https://news.alphastreet.com/bunge-global-releases-q1-2026-financial-results/

IDEX (IEX) Q1 2026 results: sales rise 9% to $887 million

IDEX Corporation (NYSE:IEX) reported strong financial results for Q1 2026, with net sales increasing 9% to $887 million and organic growth of 5%. The company achieved record orders totaling $988 million, an increase of 13%, driven by demand across its industrial segments. Profitability also improved, with diluted EPS rising 28% to $1.61, and IDEX returned $129 million to shareholders through repurchases and dividends.

https://grafa.com/en/news/united-states/idex-corp-iex-q1-2026-earnings-record-orders-guidance-increase

Idex Releases Q1 2026 Financial Results

Idex Corporation reported strong first-quarter 2026 financial results, surpassing Wall Street expectations with adjusted earnings of $2.00 per share against a $1.79 forecast. The company achieved $886.9 million in revenue, a 9.0% increase year-over-year, driven largely by its Health & Science Technologies segment. Idex also provided full-year adjusted EPS guidance between $8.35 and $8.55, reflecting confidence in its continued performance.

https://news.alphastreet.com/idex-releases-q1-2026-financial-results/

Trending Today

Crude Oil ($CRUDE) Commodity Forecast: Down 5.1% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Down 10.3% Today

DaVita Inc. ($DVA) Stock Forecast: Up 5.1% Today

Skyworks Solutions Inc. ($SWKS) Stock Forecast: Up 5.2% Today

Coty Inc. Class A ($COTY) Stock Forecast: Up 5.6% Today

Rockwell Automation Inc. ($ROK) Stock Forecast: Up 8.9% Today

Intel Corporation ($INTC) Stock Forecast: Up 11.7% Today

Quidelortho Corpoation ($QDEL) Stock Forecast: Down 5.5% Today

IDEX Corporation Price History

05.00.2026 - IEX Stock was up 2.0%

• A notable surge in Harvey Investment Co. LLC's ownership in IEX, coupled with IEX's announcement of a $1.0 billion share repurchase scheme and a quarterly dividend, likely bolstered investor confidence, driving the bullish market movement.
• Analysts' "Moderate Buy" rating and the average price target of $196.86 contributed to the positive sentiment surrounding IEX, indicating a promising outlook for the company's future performance.
• Emphasizing IEX as a stable and growth-oriented investment choice, focusing on indispensable products, strong cash flow, and reliable dividends, may have attracted more long-term investors, elevating the stock value.
• Overall, the combination of a substantial increase in ownership by a significant investor, favorable analyst ratings, and the depiction of IEX as a dependable option for stability and growth likely played a pivotal role in today's bullish market movement of IDEX Corporation.

02.02.2026 - IEX Stock was up 1.6%

• One major fund reduced its stake in IDEX Corporation, while other prominent funds like Nordea and Nuance increased their positions, reflecting mixed sentiments among institutional investors.
• Another fund significantly increased its stake in IDEX following the company's strong quarterly earnings beat and positive guidance, showing confidence in its future performance.
• Additionally, a different fund also boosted its position in IDEX after the company surpassed earnings estimates and provided optimistic guidance, reflecting the positive market sentiment towards the stock.
• Analysts raised earnings estimates for IDEX, projecting strong future performance based on the company's recent financial results and analyst upgrades, further supporting the bullish movement in the stock.

04.01.2026 - IEX Stock was up 5.2%

• IDEX (IEX) experienced a strong uptrend today supported by its robust Q4 2025 performance and optimistic projections for 2026.
• The company's success in the HST segment, fueled by demand from data centers and semiconductors, notably influenced the positive market movement.
• Significant order increase in AI-related ventures, surpassing earnings and revenue forecasts, reinforced investor faith in IDEX.
• Despite maintaining a Zacks Rank #4 (Sell) owing to adjustments in estimates, the favorable financial outcomes and outlook are likely to have eclipsed this, prompting the bullish market activity.

29.03.2026 - IEX Stock was up 6.8%

• Robust first-quarter 2026 financial results were reported by Idex Corporation, surpassing expectations with growth in adjusted earnings and revenue.
• The company's strong performance was driven by its Health & Science Technologies segment, demonstrating its adeptness at seizing market opportunities.
• Positive forward-looking guidance from Idex, with an increased adjusted EPS range for both the second quarter and full year 2026, bolstered investor confidence and contributed to the stock's upward trajectory.
• The high volume of orders, revenue growth, and improved profit outlook all indicate a favorable future for Idex Corporation, enhancing investor certainty and fueling the stock's upward momentum.

29.03.2026 - IEX Stock was up 7.1%

• IDEX Corporation reported strong financial performance in Q1 2026, exceeding revenue and EPS expectations, resulting in a notable increase in its stock value.
• The company's excellent results in its Health & Science Technologies division, along with robust orders and profitability, generated investor confidence and pushed the stock price upwards.
• IDEX's strategic emphasis on key markets, ongoing innovation, and efficient capital utilization were identified as crucial elements in its sustained growth, despite global uncertainties.
• The company's revised full-year EPS forecast and positive future prospects boosted investor trust and bolstered the bullish trend in IEX's stock price.

29.03.2026 - IEX Stock was up 5.8%

• IDEX Corporation (IEX) posted impressive Q1 2026 financial results, surpassing both EPS and revenue expectations, leading to a notable increase in its stock value.
• The exceptional performance was mainly due to strong growth in its Health & Science Technologies segment and strategic investments in key markets.
• Company leaders emphasized consistent innovation, strategic capital utilization, and a solid order backlog in HST as pivotal elements bolstering a positive outlook amidst global uncertainties.
• The decision to raise its projected full-year EPS guidance for 2026 additionally boosted investor confidence in IDEX's sustained growth path.

24.02.2026 - IEX Stock was up 1.0%

• IDEX Corp's stock demonstrated strong performance compared to competitors and major market indices, reflecting high investor confidence in the company.
• The favorable movement may be linked to the company surpassing analyst expectations in its Q4 earnings, leading to multiple price target upgrades.
• Although Nordea Investment Management AB reduced its stake in the company, this factor did not deter positive market sentiment towards IDEX Corp.
• Previous days of losses could be viewed as a short-term correction or profit-taking, with today's increase suggesting a return of bullish investor sentiment.